Clinical Trial Update: Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nivolumab in combination with chemotherapy for primary tracheal squamous cell carcinoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tracheal Squamous Cell Carcinoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: The First Affiliated Hospital of Guangzhou Medical University | Conditions: Neoplasms, Carcinoma, Squamous | Phase 2 | Status: RECRUITING